BioHealth News Archive
BioNetworking: Fermenting Innovation – Sept 27th 3:00 PM
This networking event is for BioTech Professionals in the BioHealth Capital Region. We encourage all professionals, post-docs and scientist to attend - it is…
Read MoreDigital OMICS Innovators Meetup – Meetup
Listen to, network with the hottest startup CXOs in the biohealth capital region at our first in a series of four annual meetups around…
Read MoreA Harvard Scientist Thinks He Has a Gene Test for Heart Attack Risk. He Wants to Give It Away Free
A Harvard scientist thinks he's reached a new milestone: a genetic test that helps identify people who are at high risk of having a…
Read MoreNew MCEDC Website Features to Grow Your Business
PROGRAMS AND INCENTIVES TO SPUR BUSINESS GROWTH We help you navigate available programs, grants and incentives to identify immediate opportunities and plan for long-term…
Read MoreGlycoMimetics Receives Japanese Patent For Uproleselan (GMI-1271) – Business Wire
GlycoMimetics, Inc. (NASDAQ: GLYC), a biopharmaceutical company focused on discovering and developing novel small-molecule drug candidates to treat rare diseases, announced today that the…
Read MorePopper and Co. to Present New Framework for Economic Evaluation of Diagnostics in the Era of Precision Medicine at Next Generation Dx Summit
Popper and Co., a strategy consulting and transaction advisory firm serving the needs of the medical technology and life sciences industries, announced today that…
Read MorePediatric Device Symposium – SZI Surgical Innovation Institute
Calling all pediatric cardiovascular devices $100K competition now accepting proposals We are now accepting proposals for our annual pediatric medical device pitch competition! New…
Read MoreEmmes Ranked as a Top Area Workplace for Second Consecutive Year by The Washington Post – Emmes
The Emmes Corporation today announced that it was selected as one of the best places to work in the greater Washington area. The Washington…
Read MoreRegenxBio raises $175.5M follow-on – BioCentury
RegenxBio Inc. (NASDAQ:RGNX) raised $175.5 million through the sale of 2.7 million shares at $65 in a follow-on underwritten by Morgan Stanley, BofA Merrill…
Read MoreGV’s Krishna Yeshwant on skepticism in biotech and healthcare investments – Business Insider
Venture investor Krishna Yeshwant uses a healthy amount of skepticism when vetting potential companies to invest in. His favorite time to invest is when…
Read MoreThe Best Health Care System in the World: Which One Would You Pick? – The New York Times
To better understand one of the most heated U.S. policy debates, we created a tournament to judge which of these nations has the best…
Read MoreStudy Seeks Path for Drugs to Reach Brain Tumors – University of Maryland, Baltimore
In the first such clinical trial in the United States, physician-scientists with the University of Maryland School of Medicine (UMSOM) are investigating the use…
Read MoreClearMask Awarded $25K from National Science Foundation — ClearMask
Recently, ClearMask received $25,000 in grant funding from the National Science Foundation (NSF) to support ClearMask's commercialization efforts. The funding is part of the…
Read MoreJonathan Aberman: My roadmap for our region’s innovation economy – Washington Business Journal
In last week’s Amplified column, I discussed how the traditional wisdom that small business pursues disruptive innovation and big business pursues sustaining innovation may…
Read MoreEmergent BioSolutions to Acquire Specialty Vaccines Company PaxVax
Emergent BioSolutions Inc. (NYSE: EBS) announced today that it has entered into an agreement to acquire PaxVax, a company focused on specialty vaccines that…
Read More